Growth Hormone Secretagogues & GHRH Analogs
Tesamorelin
FDA-approved for specific indicationsFDA-approved
Last reviewed: 2026-11-19
History
Theratechnologies developed tesamorelin; FDA approval began in 2010.
Key sources
Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.
Related compounds
- CJC-1295
Same target family · A 29-amino-acid chain. · Early human trials
- Examorelin
Same scientific class · A 6-amino-acid chain. · Early human trials
- Ipamorelin
Same scientific class · A 5-amino-acid chain. · Early human trials
- Modified GRF (1–29)
Same target family · A 29-amino-acid chain. · Cell/lab studies only
- Pralmorelin
Same scientific class · A 6-amino-acid chain. · Early human trials